ClinicalTrials.gg
Not yet recruitingNCT07226505Updated Nov 10, 2025

Effects of Core Strengthening Exercises for Treating TMD

An interventional study of Experimental: Group 1: Core Strengthening and Group 2: Standard TMD PT in Temporomandibular Joint Dysfunction, TMD and TMJ Internal Derangement, sponsored by Loyola University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-11-10.

Sponsored by Loyola University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Temporomandibular disorders (TMD) are commonly managed with non-invasive interventions such as manual therapy, therapeutic exercise, relaxation techniques, and patient education. Core strengthening (also known as abdominal strengthening) is a fundamental element of physical therapy that engages deep and superficial trunk musculature to enhance postural control and functional performance. Protocols such as the Shirley Sahrmann progression have demonstrated increased activation of key core stabilizing muscles. Emerging evidence suggests a potential relationship between core stability training and reductions in TMD-related pain, though improvements in functional outcomes remain inconclusive. Biomechanical links between the pelvic floor, spine, and temporomandibular joint further support the rationale for core-focused interventions. Nevertheless, few studies have isolated the effects of core strengthening on TMD symptomatology. This study seeks to determine whether the integration of core stability exercises into TMD management can reduce pain, improve function, and enhance quality of life.

Read the detailed description

This single-blinded randomized controlled trial will evaluate the effects of core strengthening exercises in addition to standard physical therapy for patients with Temporomandibular Joint Dysfunction (TMD). The study aims to determine whether integrating core stability exercises can reduce TMD-related pain, improve function, and enhance quality of life compared to standard physical therapy alone.

A total of 50 participants, aged 18-70, who have a primary complaint of TMD within the last 30 days and are willing to complete at least six physical therapy visits over a three-month period will be enrolled. Participants must speak English or have access to a verified interpreter and be able to safely participate in exercise.

Participants will be randomly assigned to one of two groups:

Group 1: Core strengthening exercises (Shirley Sahrmann progression) combined with standard TMD physical therapy, including therapeutic exercises, manual interventions, soft tissue mobilization, neuromuscular re-education, and education. Home exercise programs will support adherence.

Group 2: Standard TMD physical therapy alone, including the same therapeutic exercises, manual interventions, soft tissue mobilization, neuromuscular re-education, and education.

Key exclusion criteria include recent TMJ or spinal surgery, recent head/neck trauma or neurologic symptoms, pregnancy, concurrent physical therapy for other movement disorders, low back or pelvic health dysfunction in the past three months, use of dentures, or current chemotherapy/radiation involving the head, neck, pelvis, spine, or hip.

Participants will undergo initial evaluation, intervention sessions, and post-treatment assessment by blinded evaluating therapists to measure pain, function, and core strength outcomes. Safety will be continuously monitored throughout the study.

02

Conditions studied

  • Temporomandibular Joint Dysfunction
  • TMD
  • TMJ Internal Derangement
  • Myofascial Pain

Keywords

  • Core strengthening
  • physical therapy
  • RCT
03

In context

Temporomandibular Joint Disorders

591 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

This study's planned enrollment of 50 is above the median of 45 across 415 interventional studies indexed under Temporomandibular Joint Disorders.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

Loyola University is the lead sponsor of 134 studies on the registry; 15 are open to participants now.

Of its 26 completed or terminated interventional studies of FDA-regulated products, 23 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Who Can Participate (Inclusion Criteria):

Adults between 18 and 70 years old.

Have had jaw pain or problems with the jaw joint (TMD) in the last 30 days.

Able and willing to attend at least six physical therapy sessions over three months.

Speak English or have access to a qualified interpreter.

Able to safely do physical exercises.

Who Cannot Participate (Exclusion Criteria):

Recently had surgery on the jaw, teeth, or spine (within the last 3 months).

Recently had head or neck injuries or certain neurological problems (such as dizziness, double vision, trouble swallowing, or sudden falls).

Are pregnant or become pregnant during the study.

Currently doing physical therapy for other movement problems that could affect the study.

Have had lower back or pelvic health issues in the last 3 months.

Currently receiving chemotherapy or radiation for cancer in the head, neck, pelvis, spine, or hip.

Wear dentures or cannot safely perform exercises.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Group 1: Core Strengthening + Standard TMD Physical Therapy

    Participants in this group will receive the Shirley Sahrmann core strengthening protocol, which involves progressive levels of dynamic movements designed to maintain a neutral spine and activate deep core muscles. Exercises begin in hook-lying or supine positions, with gradual progression through five levels, and may include upper extremity movements once core control is achieved. In addition, participants will follow a structured home exercise program with daily exercises (approximately 20 minutes), supported with printed instructions and video demonstrations through the MedBridge platform.

    Behavioral: Experimental: Group 1: Core Strengthening · Behavioral: Group 2: Standard TMD PT

  • Active comparator
    Group 2: Standard TMD Physical Therapy

    Participants in this group will receive standard physical therapy for TMD, including: Therapeutic exercises (e.g., Rocabado 6x6) for jaw mobility and posture. Manual therapy to restore normal TMJ and cervical spine joint mechanics. Soft tissue mobilization targeting masticatory and cervical muscles as clinically indicated. Education on jaw rest position, diet/chewing modifications, and avoidance of parafunctional habits. Neuromuscular re-education to improve TMJ opening mechanics, including deep neck flexor activation and mirror training.

    Behavioral: Group 2: Standard TMD PT

Interventions

  • BehavioralExperimental: Group 1: Core Strengthening

    Participants perform Shirley Sahrmann core exercises (5 progressive levels maintaining neutral spine and deep core activation), possibly adding upper extremity movements. Standard TMD PT includes jaw exercises, manual therapy, soft tissue mobilization, neuromuscular re-education, and patient education. A home exercise program (\~20 min/day) is provided with printed and video instructions.

    Also known as: Shirley Sahrmann Core Stability Protocol

  • BehavioralGroup 2: Standard TMD PT

    Participants receive standard TMD PT including jaw exercises (Rocabado 6x6), manual therapy for TMJ and cervical spine, soft tissue mobilization, neuromuscular re-education to improve jaw mechanics, and education on jaw positioning, diet/chewing modifications, and parafunctional habits. A home exercise program is provided as part of treatment.

    Also known as: Rocabado 6x6 Exercises

06

What researchers measure

Primary outcomes

  1. TMD Pain (e.g., Visual Analog Scale/Numeric Pain Rating)

    Time frame: Baseline and post-intervention (6 PT sessions), assessed up to 6 weeks

Secondary outcomes

  1. Neck Disability Index (NDI)

    This measure evaluates how neck pain affects a person's ability to perform everyday activities. It uses the Neck Disability Index (NDI), a questionnaire scored from 0% to 100%, where 0% means no disability and 100% represents complete disability in daily life.

    Time frame: Baseline and post-intervention (6 PT sessions), assessed up to 6 weeks

  2. Compliance with Home Exercise Program (HEP)

    Assessed via participant-completed exercise diaries, tracking adherence to prescribed daily exercises.

    Time frame: Throughout the 6-week intervention period (daily tracking, summarized at post-intervention)

  3. Functional Measures from TMJ Scale

    This measure objectively evaluates jaw movement and functional performance, including mobility, deviation, and deflection. It uses the Temporomandibular Disorder (TMD) Dysfunction Scale, which consists of 10 questions scored from 0 to 4. The total score is converted to a percentage, where higher percentages reflect greater levels of dysfunction or disability.

    Time frame: Baseline and post-intervention (6 PT sessions), assessed up to 6 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07226505
Lead sponsor
Loyola University
Collaborators
Loyola University Chicago
Responsible party
Margaret Miller (MD, Loyola University Chicago) — Principal investigator
First posted
Nov 10, 2025
Start date
Nov 1, 2025 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Nov 10, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion